Overview: Pyruvate TestIntroduction: The Pyruvate Test measures pyruvate levels to diagnose metabolic disorders, causing fatigue or muscle weakness. Following 2023 ACMG guidelines, it uses biochemical methods for high specificity, supporting metabolic screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in biochemistry for patients with suspected mitochondrial disorders or lactic acidosis.
Other Names: Pyruvate Assay, Blood Pyruvate Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Pyruvate testing began in the 1960s with metabolic disorder research. Biochemical methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures pyruvate to diagnose metabolic disorders, guides treatment, and evaluates patients with fatigue or muscle weakness.
Test Parameters: 1. Pyruvate Level
Pretest Condition: No fasting required. Collect serum, plasma, or whole blood. Report history of fatigue, muscle weakness, or metabolic symptoms.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL), Whole Blood (EDTA, 2-5 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fatigue, muscle weakness, or family history of metabolic disorders. Include current medications, especially those affecting mitochondrial function.
Consent: Written consent required, detailing the tests purpose, metabolic disorder implications, and risks of sample collection.
Procedural Considerations: Uses enzymatic or chromatographic methods to measure pyruvate levels. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for metabolic disorder diagnosis.
Factors Affecting Result Accuracy: Improper sample storage or hemolysis can affect results. Recent exercise or diet may alter pyruvate levels.
Clinical Significance: Elevated pyruvate confirms mitochondrial disorders or lactic acidosis, guiding coenzyme Q10 or other therapies. Normal levels may require lactate testing.
Specialist Consultation: Consult a metabolic specialist or neurologist for result interpretation and treatment planning.
Additional Supporting Tests: Lactate levels, mitochondrial DNA sequencing, or muscle biopsy to confirm metabolic disorder diagnosis.
Test Limitations: Non-specific for certain metabolic disorders; clinical correlation is needed. Sample quality affects sensitivity.
References: ACMG Metabolic Guidelines, 2023; Journal of Inherited Metabolic Disease, Parikh S, 2022.
